In particular, the generation of both CD4+ and CD8+ central memory (CD44+ CD62Lhigh) lymphocytes, which are necessary to mediate protection in ACT recipients upon challenge with antigen expressing tumor cells, is observed. The gene discussed is CD4; the disease is neoplasm.